Epilepsy complicates a woman`s reproductive life. The physiological modification of the woman and the effects of antiepileptic drugs are generally the cause. Several complications may be added during treatment that requires careful monitoring. The risks in women of childbearing age associated with prenatal Valproic Acid Drug (VPA) exposure are becoming established, and updated recommendations are being made internationally for restrictions to (VPA) use and enhanced preconception counseling in this patient group.
To minimize these complications we implement same protocol in the different hospital departments to assure high quality of care for childbearing age women. As a result we remark a decrease number of patients using (VPA) and improvement of the quality of reproductive health and per consequence reducing hospital and societal costs.
Published Date: 2022-03-14; Received Date: 2022-02-09